Skip to main content

. 1992 Jun 20;304(6842):1611–1612. doi: 10.1136/bmj.304.6842.1611

Effects of long term octreotide on gall stone formation and gall bladder function.

G W Bigg-Wither ¹, K K Ho ¹, R R Grunstein ¹, C E Sullivan ¹, B D Doust ¹

PMCID: PMC1881991 PMID: 1628089

1611

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Ahrendt S. A., McGuire G. E., Pitt H. A., Lillemoe K. D. Why does somatostatin cause gallstones? Am J Surg. 1991 Jan;161(1):177–183. doi: 10.1016/0002-9610(91)90381-m. [DOI] [PubMed] [Google Scholar]
Dodds W. J., Groh W. J., Darweesh R. M., Lawson T. L., Kishk S. M., Kern M. K. Sonographic measurement of gallbladder volume. AJR Am J Roentgenol. 1985 Nov;145(5):1009–1011. doi: 10.2214/ajr.145.5.1009. [DOI] [PubMed] [Google Scholar]
Ho K. Y., Weissberger A. J., Marbach P., Lazarus L. Therapeutic efficacy of the somatostatin analog SMS 201-995 (octreotide) in acromegaly. Effects of dose and frequency and long-term safety. Ann Intern Med. 1990 Feb 1;112(3):173–181. doi: 10.7326/0003-4819-112-3-173. [DOI] [PubMed] [Google Scholar]
Sassolas G., Harris A. G., James-Deidier A. Long term effect of incremental doses of the somatostatin analog SMS 201-995 in 58 acromegalic patients. French SMS 201-995 approximately equal to Acromegaly Study Group. J Clin Endocrinol Metab. 1990 Aug;71(2):391–397. doi: 10.1210/jcem-71-2-391. [DOI] [PubMed] [Google Scholar]
van Liessum P. A., Hopman W. P., Pieters G. F., Jansen J. B., Smals A. G., Rosenbusch G., Kloppenborg P. W., Lamers C. B. Postprandial gallbladder motility during long term treatment with the long-acting somatostatin analog SMS 201-995 in acromegaly. J Clin Endocrinol Metab. 1989 Sep;69(3):557–562. doi: 10.1210/jcem-69-3-557. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES